These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12951613)

  • 1. [On studies with medicines after commercialization, obligations or prohibitions?].
    Sádaba B
    An Sist Sanit Navar; 2003; 26(2):187-93. PubMed ID: 12951613
    [No Abstract]   [Full Text] [Related]  

  • 2. Should the patent system for new medicines be abolished?
    DiMasi JA; Grabowski HG
    Clin Pharmacol Ther; 2007 Nov; 82(5):488-90. PubMed ID: 17952100
    [No Abstract]   [Full Text] [Related]  

  • 3. "Obvious to try": a proper patentability standard in the pharmaceutical arts?
    Trask AV
    Fordham Law Rev; 2008 Apr; 76(5):2625-68. PubMed ID: 18546581
    [No Abstract]   [Full Text] [Related]  

  • 4. Enforcing pharmaceutical and biotech patent rights in China.
    Zhang YP; Deng MM
    Nat Biotechnol; 2008 Nov; 26(11):1235-40. PubMed ID: 18997760
    [No Abstract]   [Full Text] [Related]  

  • 5. Justices expand rights to experiment with patented drugs.
    Pollack A
    N Y Times Web; 2005 Jun; ():C1, C8. PubMed ID: 15966121
    [No Abstract]   [Full Text] [Related]  

  • 6. Will the RACE for Children Act lead to new treatments for pediatric cancer?
    Fink JL
    Cancer; 2017 Jan; 123(2):189. PubMed ID: 28067946
    [No Abstract]   [Full Text] [Related]  

  • 7. Protect pharmaceutical innovation.
    Musselwhite LW; Andrews J
    Science; 2010 Jun; 328(5984):1354; author reply 1354-5. PubMed ID: 20538934
    [No Abstract]   [Full Text] [Related]  

  • 8. Intellectual property. Fixing the legal framework for pharmaceutical research.
    Knowles SM
    Science; 2010 Feb; 327(5969):1083-4. PubMed ID: 20150445
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of similar biotherapeutic products: scientific and regulatory challenges.
    Griffiths E; Thorpe R; Wadhwa M; Sohn Y
    Biologicals; 2011 Sep; 39(5):249. PubMed ID: 21925898
    [No Abstract]   [Full Text] [Related]  

  • 10. Stanford program gives discoveries a shot at commercialization.
    May M
    Nat Med; 2011 Nov; 17(11):1326-7. PubMed ID: 22064392
    [No Abstract]   [Full Text] [Related]  

  • 11. Are patents impeding medical care and innovation?
    Gold ER; Kaplan W; Orbinski J; Harland-Logan S; N-Marandi S
    PLoS Med; 2010 Jan; 7(1):e1000208. PubMed ID: 20052274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effectivity of data obtention previous to drug commercialization: utopy or reality?].
    Soto Alvarez J
    Med Clin (Barc); 2006 Nov; 127(19):736-7. PubMed ID: 17198650
    [No Abstract]   [Full Text] [Related]  

  • 13. Using market-exclusivity incentives to promote pharmaceutical innovation.
    Kesselheim AS
    N Engl J Med; 2010 Nov; 363(19):1855-62. PubMed ID: 21047231
    [No Abstract]   [Full Text] [Related]  

  • 14. Report suggests steps to improve safety of drug supply.
    Traynor K
    Am J Health Syst Pharm; 2011 Sep; 68(17):1570, 1574. PubMed ID: 21856799
    [No Abstract]   [Full Text] [Related]  

  • 15. THE IMPACT OF THE NEW FOOD AND DRUG LAWS AND REGULATIONS ON THE SPONSORS OF CLINICAL TRIALS.
    HEIN JW
    J Oral Ther Pharmacol; 1964 Jul; 1():85-92. PubMed ID: 14204420
    [No Abstract]   [Full Text] [Related]  

  • 16. The legal regulation of primate research.
    Fox M
    Am J Bioeth; 2009 May; 9(5):13-5. PubMed ID: 19396672
    [No Abstract]   [Full Text] [Related]  

  • 17. Strengths and limitations of the federal guidance on synthetic DNA.
    Adam L; Kozar M; Letort G; Mirat O; Srivastava A; Stewart T; Wilson ML; Peccoud J
    Nat Biotechnol; 2011 Mar; 29(3):208-10. PubMed ID: 21390018
    [No Abstract]   [Full Text] [Related]  

  • 18. China's perspective on similar biotherapeutic products.
    Liang C; Wang J
    Biologicals; 2011 Sep; 39(5):312-6. PubMed ID: 21924622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Type Code of the pharmaceutical industry for the protection of personal data in the field of clinical research and pharmaceutical surveillance].
    Fraguas L; Francés M; Riesgo P
    Rev Derecho Genoma Hum; 2010; (32):243-56. PubMed ID: 21192439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WHO expert committee on specifications for pharmaceutical preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2013; (981):i-xi, 1-188. PubMed ID: 23821930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.